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Abstract. Hazard ratios can be approximated by data extracted from
published Kaplan-Meier curves. Recently, this curve approach has been
extended beyond hazard ratio approximation with the capability of con-
structing time-to-event data at the individual level. In this article, we in-
troduce a Stata command ipdfc to implement the reconstruction method
to convert Kaplan-Meier curves to time-to-event data. Examples are given
to illustrate how to use the command.
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1 Introduction
The hazard ratio is often recommended as an appropriate effect measure in the
analysis of randomized controlled trials with time-to-event outcomes (Parmar et
al. (1989), Deeks et al. (2008)) and has become the de facto standard approach
to analysis. In meta-analysis of aggregated time-to-event data across trials, an
essential step is to extract the (log) hazard ratio and its variance from published
trial reports. Various extraction methods have been described (Parmar et al.
(1989), Williamson et al. (2002) and Tierney et al. (2007)), including direct and
indirect estimates of hazard ratios based on 95% confidence intervals, P -values
for the logrank test or the Mantel-Haenszel test, and regression coefficients in
the Cox proportional hazards model. An approximation to hazard ratios can
also be derived by a “curve approach”, as described by Parmar et al. (1989) and
Tierney et al. (2007). The curve approach makes use the extracted ordinate (y-)
and abscissa (x-) values from the Kaplan-Meier curve, to calculate hazard ratios
for each time interval for which the number of patients at risk was reported. The
overall hazard ratio during the follow-up phase is then derived by a weighted
sum of the individual estimates of hazard ratios across time intervals, with the
weights inversely proportional to the variance of each estimate (Parmar et al.
(1989)).
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The curve approach has been extended (Guyot et al. (2012)) beyond the estima-
tion of hazard ratios to the reconstruction of time-to-event data at the individual
level. Availability of reconstructed individual-level data allows one to fit alter-
native models if desired in secondary analyses. Because non-proportional haz-
ards are increasingly reported in trials, alternative measures, such as restricted
mean survival time, that do not require the proportional hazards assumption,
may have a more intuitive interpretation under non-proportional hazards (Roys-
ton and Parmar (2011)). As the proportional hazards assumption may not be
satisfied for all trials in a meta-analysis, alternative effect measures to hazard
ratios may be more appropriate in such settings (Wei et al. (2015)). However,
by definition, newly developed effect measures are not reported in earlier trial
publications. The use of these measures therefore relies either on collaborative
sharing of individual-level data or on methods that enable reconstruction of such
data from trial reports.
The reconstruction algorithm was written as an R function (Guyot et al. (2012)).
In this article, we present an implementation of this algorithm with improve-
ments by introducing a Stata command ipdfc, which has the following features:
• Makes use of the curve approach to reconstructing individual-level time-
to-event data based on the published Kaplan-Meier curves;
• Utilizes the number of patients at risk, as reported in the trial publication;
• Can identify which extracted time points correspond to the lower and
upper end-point of each time interval in the risk table;
• Can use survival/failure probabilities/percentages as data input;
• Incorporates correction of monotonicity violators in the extracted data for
survival/failure probabilities/percentages.
In the following section, we briefly overview the methods underpinning the ipdfc
command introduced in this article. This is followed by detailed descriptions
of syntax, options and saved results. We then demonstrate its application to
two examples from trial publications, and assess the approximation accuracy by
comparing summary statistics between the reconstructed data and the original
publications. We close with a discussion.
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2 Methods
2.1 Extracting data from published Kaplan-Meier curves
The reconstruction of time-to-event observations is based on data extracted from
published Kaplan-Meier curves. In such curves, the x-values usually represent
the follow-up time since randomization; the y-values may represent the survival
probabilities at the corresponding time points. As an alternative to survival
probabilities, the y-values may be survival percentages, failure probabilities or
percentages, as specified in the trial publication. All these measures can be
transformed arithmetically into survival probabilities. In addition to data from
curves, the number of patients randomized into each arm of a trial should be
extracted from publications.
The DigitizeIt (http://www.digitizeit.de/) software application is a suitable tool
for extracting data from a graphical image. Data extraction using this software is
far more rapid, detailed, accurate and reliable than by applying pencil and ruler
methods manually to a reduced image of the graph. If a curve is displayed as a
clearly defined, unbroken line, DigitizeIt can automatically read off the x- and y-
values at a large number of time points. This helps to ensure the good quality
of data required as input in the reconstruction of time-to-event observations.
However, if the curve is presented as a broken (e.g. dashed) line, the operator
must extract data semi-manually by clicking on individual points on the curve
using a mouse. Since each click returns only one data point, many clicks must
be made to obtain sufficient data when there are many jumps in the curve. In
contrast, within a specific time interval where there are few events or where the
survival curves are flat, little information is available and correspondingly few
clicks are required.
In addition, it is important to extract the number of patients at risk for each
arm at a regular time intervals during the follow-up. This information, usually
known as the risk table, is often presented beneath the published Kaplan-Meier
curves. The accuracy of the approximated time-to-event data can be improved
by incorporating information provided in the risk table (Tierney et al. (2007)).
2.2 Adjusting monotonicity violators
Since a survival function is by definition monotone decreasing with time, the
y-values extracted from a survival curve should also be monotone when ordered
by the corresponding x-values. However, there may be violators among the ex-
tracted data such that the monotonicity constraint is not satisfied. This is due
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to publication quality of the curves or to errors in controlling the mouse clicks
(Guyot et al. (2012)). It should be noted that the reconstruction algorithm
involves estimating survival functions. Monotonicity violators can lead to incor-
rect estimates for the number of events, and subsequently incorrect estimates
of the survival function, which prevents the reconstruction from working. It is
therefore crucial to correct the values for violators to ensure monotonicity. Since
violators are often multiple, a systematic method is required.
In the ipdfc command, we incorporate alternative methods for the correction of
violators. The first method, isotonic regression (Barlow et al. (1972)), may help
to detect violators and correct their values by using a Pool-Adjacent-Violators
(PAV) algorithm. Adjacent violators occur where a pair of adjacent times
and corresponding survival probabilities is inappropriately ordered, e.g. time
= (1.0,1.1), survival = (0.91, 0.92). Briefly, the PAV algorithm replaces the
adjacent violators with their mean so that the data satisfy the monotonicity
constraint. The technique has been recently coded in a Stata command irax
(van Putten and Royston (2014)), which can be called in our command. We
also consider an alternative. We replace the value of a violator by the value of
its adjacent violator, such that the corrected data satisfy the monotonicity. We
expect the use of either method will lead to similar results because the absolute
difference between the values of adjacent violators is often too small to have a
material influence on the resulting data.
2.3 Algorithm to reconstruct survival data
We now briefly describe the algorithm underpinning the command ipdfc. We
start with introducing notations. Let Sk denote survival probabilities at time
tk, where (k = 1, 2, ...,K) and K is the total number of data points extracted.
The survival probabilities Sk and the corresponding time tk may be extracted
from respective y- and x-coordinates of a Kaplan-Meier curve. Let nriski denote
the number of patients at risk at time triski, where i = 1, ..., T, with T as the
number of intervals where the number of patients at risk is reported. The number
of extracted data points K is often much greater than T , the total number of
intervals at the risk table. If the risk table is not reported, we have T = 1.
The four quantities Sk, tk, nriski and triski are the required input in the algo-
rithm. As mentioned above, the number of patients at risk, if available, should
be included in the algorithm. Otherwise if T = 1, the number of patients ran-
domized to each arm should be included to the algorithm. The total number of
events D can also be used in the reconstruction.
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In the algorithm, we will estimate the following quantities: the number of cen-
soring ĉk, the number of events d̂k, the censoring time ĉtimek and event time
d̂timek. To estimate these quantities, we implement the algorithm described in
Guyot et al. (2012) by adding three new components for improvements. First,
we calculate loweri and upperi by using the input data tk, triski. Here loweri
and upperi are respectively the indices for the first and last time points extracted
from the time interval [triski, triski+1]. For each of such time interval, loweri
is equal to min{k : tk ≥ triski}, and upperi is equal to max{k : tk ≤ triski+1}.
Thus, loweri and upperi are not required as data input as in the R code of Guyot
et al. (2012). Second, we adjust the values of monotonicity violators by using
isotonic regression or its alternative as just described. Third, we extend the
algorithm to the situation when the number at risk is reported at the last time
interval, at which we allow the calculation of the number of censoring following
the same methods as those for the other intervals. The full algorithm is given
in the appendix of this article.
3 The ipdfc command
3.1 Syntax










This syntax converts data extracted from a Kaplan-Meier curve to time-to-event
data. It should be noted that the syntax does not handle more than one sample
at once. When dealing with a trial having more than one arm, the syntax
converts data extracted from one curve at a time to time-to-event data for the
respective arm. This should be done for all arms one by one, and further data
management is needed to amalgamate the data from all arms of a trial, if the
data are from a trial, as seen in the examples given later in this article.
3.2 Required input
surv(varname) specifies the data extracted from the ordinate (y-axis) of a pub-
lished Kaplan-Meier curve. It can be survival probabilities, survival percentages,
failure probabilities or failure percentages. By default, varname is assumed to
contain survival percentages.
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tstart(varname) specifies the time since randomization as extracted from the
abscissa (x-axis) of a published Kaplan-Meier curve. The time could be in any
units (e.g. days, months, years) as specified in the publication.
trisk(varname) specifies the times at which the numbers of patients at risk in
trisk(). Set varname = 0 if only the total number of patients in the sample
is known.
nrisk(varname) supplies the number of patients at risk for each time in trisk().
Both trisk() and nrisk() may often be found in a risk table displayed beneath
published Kaplan-Meier curves. If no risk table is available, specify nrisk() as
the number of patients in the sample and trisk(varname) as 0.
generate(varname1 varname2) generates the time-to-event outputs extracted
from the input information. varname1 varname2 specify two new variables,
time to event and an event indicator (1 = event, 0 = censored). For example,






) saves the reconstructed survival data to a file
named filename.dta.
3.3 Options
probability signifies that varname in surv(varname) contains probabilities
rather than percentages.
failure signifies that varname in surv(varname) contains failure information
rather than the default survival information.
isotonic invokes use of isotonic regression to adjust values which violate the
time-related monotonicity in surv(varname). By default, an alternative, sim-
pler method is used to correct the values of violators, by replacing the value of
a violator by the value of its adjacent violator.
totevents(#) is the total number of events and is used to adjust the number
of observations censored in the final interval of the risk table.
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4 Illustrative Examples
4.1 Example 1: Head and neck cancer trial
Our first example is a two-arm randomized controlled trial published in Bonner
et al. (2006). A total of 424 participants with locoregionally advanced head
and neck cancer were randomized to receive either radiotherapy plus cetuximab
or radiotherapy alone. The primary outcome was the duration of locoregional
control. Both Kaplan-Meier curves and the hazard ratio were reported. This
example was first used in Guyot et al. (2012) to illustrate the application of
the reconstruction method. Here we use ipdfc to reconstruct the survival data,
to illustrate how it performs compared with Guyot et al. (2012) and with the
results in the original publication. We run the steps for each arm separately to
obtain arm-specific data based on the associated Kaplan-Meier curve from the
trial report.
We read in a text file for the control arm by calling import delimited.
. import delimited using "Head_and_neck_arm0.txt", clear
The text file contains four variables: ts and s as the data extracted from the
x-axis and y-axis of a curve; and trisk and nrisk from the risk table.
We regenerate data for the control group by calling ipdfc.
. ipdfc, surv(s) tstart(ts) trisk(trisk) nrisk(nrisk) isotonic ///
> generate(t_ipd event_ipd) saving(temp0)
Since the extracted y-values are survival percentages in this example, we need
not call either probability or failure to convert s. However, we call the option
isotonic to evoke isotonic regression to correct monotonicity violators. The
regenerated survival data are stored in the file temp0.dta.
We run the following steps for the treatment group.
. import delimited using "Head_and_neck_arm1.txt", clear
. ipdfc, surv(s) tstart(ts) trisk(trisk) nrisk(nrisk) isotonic ///
> generate(t_ipd event_ipd) saving(temp1)
The regenerated survival data are stored in the file temp1.dta.
The data simulated from both arms are then combined and specified with an
arm indicator.
. use temp0, clear
. gen byte arm = 0
. append using temp1
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. replace arm = 1 if missing(arm)
In the amalgamated data, there are three variables t ipd, event ipd and arm,
which are time to an event, event indicator and arm indicator, respectively. We
label the arm indicator as “Radiotherapy” and “Radiotherapy plus cetuximab”,
as specified in the trial publication.
. label define ARM 0 "Radiotherapy" 1 "Radiotherapy plus cetuximab"
. label values arm ARM
We set time as the time to failure.
. stset t_ipd, failure(event_ipd)
By calling the sts graph, we reconstruct the survival curves.
. sts graph, by(arm) title("") xlabel(0(10)70) ylabel(0(0.2)1) ///
> risktable(0(10)50, order(2 "Radiotherapy" 1 "Radiotherapy plus" bottom(msize(5)))) ///
> xtitle("Months") l2title("Locoregional Control") ///
> scheme(s2color) graphregion(fcolor(white)) ///
> plot1opts(lpattern(solid) lcolor(gs12)) ///
> plot2opts(lpattern(solid) lcolor(black)) ///
> text(-0.38 -9.4 "Cetuximab") ///
> legend(off) ///
> text (0.52 53 "Radiotherapy plus Cetuximab") text(0.20 60 "Radiotherapy")
The survival analysis is carried out by calling stcox arm.
. stcox arm
failure _d: event_ipd
analysis time _t: t_ipd
Cox regression -- Breslow method for ties
No. of subjects = 424 Number of obs = 424
No. of failures = 241
Time at risk = 8412.821526
LR chi2(1) = 6.31
Log likelihood = -1320.1899 Prob > chi2 = 0.0120
_t Haz. Ratio Std. Err. z P>|z| [95% Conf. Interval]
arm .7208993 .0947487 -2.49 0.013 .5571859 .9327152
The reconstructed Kaplan-Meier curves curves (see Figure 1) look similar to the
published curves (Bonner et al. (2006)). There is only a small discrepancy in
the number of patients at risk in the radiotherapy plus Cetuximab arm. For
this arm, based on the reconstructed data the number of patients at risk are
211, 130, 94, 67, 35 and 10, which are similar though not identical to 211, 143,
101, 66, 35 and 9 in the original publication. The discrepancy in the risk table
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Figure 1: Reconstructed Kaplan-Meier curves for locoregional control among
patients with head and neck cancer (Bonner et al. (2006)). Patients are ran-
domized to receive radiotherapy plus cetuximab or radiotherapy alone.
between the approximation (see Figure 1) and the original publication is very
small for the radiotherapy arm.
In Table 1, we report percentages of patients surviving 1, 2 and 3 years, median
duration of locoregional control and hazard ratio estimates. The estimates of
percentages of surviving and median time to event are close to those in the orig-
inal publication. The hazard ratio (0.72, 95%CI: 0.56-0.93) estimated by our
command is close to 0.73(95%: 0.57-0.94) estimated by Guyot et al. (2012).
Since we digitize the data independently of Guyot et al. (2012), we do not ex-
pect to obtain identical data nor identical results. However, both approximated
hazard ratios are similar to published hazard ratio (0.68, 95 %CI: 0.52-0.89),
but not identical.
4.2 Example 2: ICON7 trial
Our second example is ICON7, a two-arm randomized controlled trial in ad-
vanced ovarian cancer (Perren et al. (2011)). A total of 1528 women were ran-
domized to receive either standard chemotherapy plus bevacizumab or standard
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Table 1: Example 1. Comparison of summary measures estimated from publi-
cation and their corresponding reconstructed data
Original publication Guyot (2012) ipdfc
Radiotherapy arm Percent(95% CI) Percent (95% CI)
Percent surviving 1 year 55 56.1 (49.6,63.3) 56.9 (49.9, 63.2)
Percent surviving 2 year 41 41.1 (34.7,48.6) 40.9 (34.2, 47.5)
Percent surviving 3 year 34 34.7 (28.4,42.5) 33.5 (27.1, 40.1)
Median duration 14.9 14.9 (11.9,23.0) 16.1 (11.9, 20.4)
Radiotherapy plus cetuximab arm Percent (95% CI) Percent (95% CI)
Survival rate at 1 year 63 64.0 (57.8,70.9) 65.4 (58.2, 71.6)
Survival rate at 2 years 50 50.4 (43.9,57.8) 51.0 (43.3, 58.6)
Survival rate at 3 years 47 46.7 (40.1,54.4) 49.6 (40.4, 55.7)
Median duration 24.4 24.3 (15.7,45.7) 23.7 (15.6, 46.8)
Hazard ratio with 95%CI
0.68 (0.52,0.89) 0.73(0.57,0.94) 0.72 (0.56,0.93)
chemotherapy alone. From the analysis based on data with 30 months follow-
up, Perren et al. (2011) concluded that bevacizumab improved progression-free
survival (PFS) in this population, with HR 0.81 (95%CI, 0.70 to 0.94; P = 0.004
from a logrank test). Perren et al. (2011) found significant non-proportional
hazards (P < 0.001) of the treatment effect. Kaplan-Meier curves and the as-
sociated risk table for PFS were reported in their Figure 2a, based on which
we reconstructed the survival data using ipdfc. Also, we make use of the total
number of events tot because they were available.
. local tot0 = 464
. local tot1 = 470
. import delimited using "ICON7_data_arm0.txt", clear
. ipdfc, surv(s) tstart(ts) trisk(trisk) nrisk(nrisk) probability isotonic ///
> tot(`tot0´) generate(t_ipd event_ipd) saving(temp0)
. import delimited using "ICON7_data_arm1.txt", clear
. ipdfc, surv(s) tstart(ts) trisk(trisk) nrisk(nrisk) probability isotonic ///
> tot(`tot1´) generate(t_ipd event_ipd) saving(temp1)
In this example, the extracted y-values are survival probabilities. According
in the above codes we call the option probability to specify that surv(s)
represents survival probabilities other than survival percentages.
The reconstructed Kaplan-Meier curves in Figure 2 look similar to those in
the original publication (Perren et al. (2011)). The number of patients at
risk is also well approximated, with most numbers identical to those in the
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Figure 2: Reconstructed Kaplan-Meier curves for progression-free survival ac-
cording to treatment group in ICON7 (Perren et al. (2011)). Patients are
randomized to receive standard chemotherapy plus Bavacizumab or standard
chemotherapy alone.
original publication. The little discrepancies lie in 6 months and 12 months.
The numbers of patients at risk are 694 at 6 moths and 465 at 12 months based
on the approximated data, which compared similarly though not identical to 693
at 6 month and 464 at 12 month as reported in the original publication. The
estimated hazard ratios, median survival time as well as the P -values from the
log-rank test are also similar to those in the original publication (see table 2).
4.3 Example 3: EUROPA trial
Our third example EUROPA is a two-arm randomized placebo-controlled trial
evaluating the efficacy of perindopril in reduction of cardiovascular events among
patients with stable coronary artery disease (Fox et al. (2003)). In this trial,
12218 patients were randomly assigned perindopril 8 mg once daily (n=6110), or
placebo (n=6108). Kaplan-Meier curves and the associated risk table were pre-
sented in Figure 2 of their trial report. In Fox et al. (2003) the Cox proportional
hazards model was used, but the hazard ratio estimate was not reported. It was
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Table 2: Example 2. Comparison of summary measures estimated from publi-
cation and their corresponding reconstructed data
Original publication Reconstructed data
Log-rank test P=0.004 P=0.009
Non-PH test P<0.001 P<0.001
Hazard ratio 0.81 (95%: 0.70 - 0.94) 0.83 (95%: 0.72 - 0.96)
Median survival time
Chemotherapy arm 17.3 17.5 (95%CI: 16.1 - 18.7)
Bevacizumab arm 19.0 19.1 (95%CI: 18.3 - 19.9)
reported in Fox et al. (2003) that perindopril treatment was associated with a
significant reduction in the composite events (cardiovasular mortality, non-fatal
myocardial infarction, and resuscitated cardia arrest), with P -value = 0.0003
from a log-rank test and absolute risk reduction 1.9%.
We extracted the failure percentages and the associated time points respectively
from y-axis and x-axis of the Kaplan-Meier curves in their Figure 2. In the
following codes, we evoke the option failure in the command ipdfc to spec-
ify that the input data are failure percentages instead of the default, survival
percentages.
. import delimited using "europa_data_arm0.txt", clear
. ipdfc, surv(s) tstart(ts) trisk(trisk) nrisk(nrisk) failure isotonic ///
> generate(t_ipd event_ipd) saving(temp0)
. import delimited using "europa_data_arm1.txt", clear
. ipdfc, surv(s) tstart(ts) trisk(trisk) nrisk(nrisk) failure isotonic ///
> generate(t_ipd event_ipd) saving(temp1)
The Kaplan-Meier curves from the reconstructed data are presented in Figure
3. It is clear that the reconstructed curves appear nearly identical to the orig-
inal. The reconstructed curves correctly reflect that the benefit of perindopril
treatment began to appear at 1 year and gradually increased throughout the
follow-up of the trial. The numbers of patients at risk are also very similar to
the reported values, with only a small discrepancy in the placebo arm in 2 years
of follow-up (5781 in the original report vs 5783 as the reconstructed data).
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Figure 3: Reconstructed Kaplan-Meier curves for time to first occurrence of
event. Patients are randomly assigned to perindopril treatment or placebo,
EUROPA trial (Fox et al. (2003)).
Table 3: Example 3. Comparison of summary measures estimated from publi-
cation and their corresponding reconstructed data
Publication ipdfc ipdfc
with isotonic without isotonic
Log-rank test P=0.0003 P=0.0006 P=0.0006
Absolute Risk Reduction 1.9% 1.82% 1.80%
(95%CI) (0.80% - 2.84%) (0.80% - 2.82%)
Hazard ratio NA 0.81 0.81
(95%CI) (0.72 - 0.91) (0.72 - 0.92)
Using the reconstructed data, we obtain P -value = 0.0006 from a log-rank test
(Table 3). Similar to the original report, this result also suggests that perindopril
treatment was associated with a significant reduction in the composite events.
We estimate the absolute risk reduction as 1.82%, looking similarly to 1.9% in the
original publication. We are able to obtain the 95% confidence interval (0.80%
to 2.84%) for this based on the reconstructed data. Using Cox proportional
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hazards model, we obtain the hazard ratio estimate 0.81 (95%CI : 0.72− 0.91).
Table 3 shows that the correction of monotonicity violators by isotonic regression
and by the default method lead to very similar results.
The availability of Kaplan-Meier curves has enabled us to reconstruct the time-
to-event data and calculate the hazard ratio, which was not reported for this
trial. This would be particularly helpful if this trial was included in a meta-
analysis where the hazard ratio is used as an effect measure.
5 Discussion
In this article, we provide a Stata command ipdfc to implement the algorithm of
reconstructing time-to-event data based on the information extracted from pub-
lished Kaplan-Meier curves. Our command has greater flexibility, incorporating
several additional features. It requires fewer inputs, automatically corrects data
inconsistency which violates monotonicity, and allows one to utilize the number
of patients at risk at the final interval, if reported.
Example 1 shows that the estimates of summary statistics (Table 1) based on
ipdfc are similar to those by Guyot et al. (2012). Some estimates are better
approximations than others. The approximations to median times to event are
very close to those in the original publication (Perren et al. (2011)). The
approximated hazard ratio is close to but not identical to that reported in the
original publication. This small discrepancy is possibly due to the numbers and
positioning of events not being entirely accurately estimated by the algorithm.
Although non-proportional hazards are evident in ICON7, the reconstructed
Kaplan-Meiers curves and hazard ratio estimate are in reasonable agreement
with those from the trial publication (see table 2). This suggests that non-
proportional hazards may not much affect the approximation accuracy. How-
ever, further empirical evaluation of ipdfc in a larger number of trials, with
or without obvious non-proportional hazards, is desirable. This is a topic for
further research.
Where hazard ratios are not reported but Kaplan-Meier curves are available,
the command ipdfc is particularly helpful as it enables the reconstruction of
time-to-event data and hence allows for re-analysis of the data. For the EU-
ROPA trial, we are able to obtain the estimate of hazard ratio as well as the
95% confidence interval for the absolute risk reduction, both of which were not
reported in the trial publication. It is shown that the recovered Kaplan-Meier
curves and the associated risk table are both very similar to the originals. This
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is perhaps due to the large sample size in this trial and the accuracy of the
reconstructed data increases accordingly.
We conclude that ipdfc appears to perform quite well in regenerating survival
data, sufficient to produce reasonable approximations to summary statistics in
time-to-event analysis.
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Appendix
Algorithm Reconstructing survival data (adapted from Guyot et al(2012))
Require: The data extracted from published survival curves.
Sk: survival percentages as extracted from y-axis, k = 1, 2, ...,K. Here K is
the total number of extracted data points
tk: time from randomization as extracted from x-axis.
nriski: number of patients at risk at time triski, i = 1, ..., T . Here T is the
number of intervals where the number of patients at risk is reported.
triski: time reported at the risk table.
Ensure: Sk+1 ≤ Sk for all k to meet the monotonicity constraint.
Set loweri = min{k : tk ≥ triski}, and upperi = max{k : tk ≤ triski+1}.
if i < T − 1 and T > 1 then
Step 1 Calculate n̂ci, the number of censored at time [triski, triski+1] by
n̂ci = Sloweri+1/Sloweri × nriski − nriski+1.
Step 2 Distribute n̂ci censored time evenly within [triski, triski+1]. The
censored time is then
ĉtimec = tloweri + c× (tloweri+1 − tloweri)/(n̂ci + 1),
where c = 1, ..., n̂ci. We can then calculate the number of censored events n̂ck
in extracted intervals [tk, tk+1], which is within [triski, triski+1].
Step 3 Calculate the number of events at tk as





The n̂k is the estimated number at risk at time tk, Ŝ
KM
last(k) is the estimated
survival probability at time tlast(k) with
last(k) =
{
1, if k = 1
k′, otherwise.
Note that tk′ ≤ tk, and k′ is such that the latest event occurs at tk′ and
there are no events in (tk′ , tk). The estimated number of patients at risk at
time tk+1 is then n̂k+1 = n̂k − n̂dk − n̂ck, where k ∈ [loweri, upperi]. Thus
n̂riski+1 = n̂upperi+1.
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Step 4 Set ∆t = n̂riski+1 − nriski+1.
if ∆t 6= 0 then
Adjust the estimated number of censored in time interval [triski, triski+1]
by setting
n̂ci = n̂ci + (n̂riski+1 − nriski+1).
We then repeat Step 1-4 until n̂riski+1 = nriski+1.
end if ∆t = 0
Step 5 Repeat Step 1-4 until i + 1 = T .
end if i + 1 == T or T == 1
if i == T or (i == 1 and T == 1) then
Step 6 Approximate n̂cT within interval [triskT−1, triskT ] by setting
n̂cT = min








We then run Step 2-3 for the last interval [triskT−1, triskT ] .
end if
if the total number of events D is not given then
Stop the algorithm.
end if











k=1 n̂dk < D then
Step 8 Adjust the number of censored n̂cT by setting






Repeat Step 2-3, and Step 7-8 for the last interval.
end if
end if
